Date: 2013-02-12
Type of information:
Compound: EB66® cell line
Company: Vivalis (France) undisclosed North American animal health vaccine company
Therapeutic area: Veterinary medicine
Type agreement: licensing
Action mechanism:
Disease:
Details: Vivalis has signed a research license agreement with the North American animal health vaccine company. The license allows for the assessment of several viruses in EB66® cells. Terms of the agreement were not disclosed.
Financial terms:
Latest news:
